NCCN

NCCN Updates Clinical Practice Guideline for Breast Cancer

03/15/2021

Janelle Bradley

The National Comprehensive Cancer Network released an update to its clinical practice guideline for breast cancer.

The National Comprehensive...

03/15/2021

Journal of Clinical Pathways

Conference Coverage

NCCN Guideline Adherence Associated With Improved Patient Outcomes in Anal Cancer

01/15/2021

Journal of Clinical Pathways

Videos

Real-World Adherence to NCCN Guidelines in Advanced Classical Hodgkin Lymphoma

01/14/2021

Christopher Yasenchak, MD, discusses real-world adherence to National Comprehensive Cancer Network (NCCN) Guidelines regarding PET/CT usage and reported Deuville scores in advanced stage classical Hodgkin lymphoma.

Christopher Yasenchak, MD,...

01/14/2021

Journal of Clinical Pathways

ENGAGING EXPERTS

Ovarian Cancer Maintenance: PRIMA, PAOLA-1, VELIA, and Others

06/05/2020

Michael Birrer, MD, PhD, director of the Winthrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, discusses the latest PARP inhibitor indications for frontline maintenance in ovarian cancer, as well as the...

Michael Birrer, MD, PhD,...

06/05/2020

Journal of Clinical Pathways

Guideline Updates

Multiple Treatment Guideline Updates Released for Lung Cancer

05/19/2020

The National Comprehensive Cancer Network (NCCN) and the International Association for the Study of Lung Cancer (IASLC) released an updated treatment guideline for non-small cell lung cancer (NSCLC) and treatment...

The...

05/19/2020

Journal of Clinical Pathways

News

Genetic Testing Underutilized in Women With History of Ovarian Cancer

08/22/2017

JCP Editors

Less than 20% of patients with a history of ovarian cancer meeting National Comprehensive Cancer Network (NCCN) guidelines have undergone genetic testing or have discussed testing with their health care...

Less...

08/22/2017

Journal of Clinical Pathways

Research in Review

Benefits and Shortcomings of Oncology Value Frameworks for Payers

08/03/2017

JCP Editors

Multiple areas have been identified where oncology value frameworks can be revised in order to increase their utility to payers, according to a study in the Journal of Managed Care & Specialty Pharmacy (June...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

CML Treatment Decisions Should Factor in Cardiovascular Disease Risk

07/27/2017

JCP Editors

Cardiovascular disease rates and its associated risks are increased in patients with chronic myelogenous leukemia (CML) treated by community-based oncologists and should impact treatment decisions, according to a...

...

07/27/2017

Journal of Clinical Pathways

Clinical Pathways for Advance Stage Gastric Cancer: Standardizing Practice to Decrease Variability and Improve Outcomes

06/13/2017

EXECUTIVE SUMMARY Gastric cancer is the fifth most diagnosed cancer worldwide and the third leading cause of cancer deaths. In the United States and other countries with low rates of gastric cancer, the population...

...

06/13/2017

Journal of Clinical Pathways

Research in Review

Prostate Cancer Testing Guidelines Omit Critical Genetic Features

06/13/2017

JCP Editors

Current National Comprehensive Cancer Network (NCCN) guidelines and Gleason scores cannot reliably stratify patients with risk of prostate cancer for the presence or absence of pathogenic germline variants,...

...

06/13/2017

Journal of Clinical Pathways